Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

Diagnosing cerebral ischemia with door-to-thrombolysis times below 20 minutes.

Pihlasviita S, Mattila OS, Ritvonen J, Sibolt G, Curtze S, Strbian D, Harve H, Pystynen M, Kuisma M, Tatlisumak T, Lindsberg PJ.

Neurology. 2018 Jul 11. pii: 10.1212/WNL.0000000000005954. doi: 10.1212/WNL.0000000000005954. [Epub ahead of print]

PMID:
29997196
2.

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators.

N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.

PMID:
29766772
3.

Blood pressure levels in the acute phase after intracerebral hemorrhage are associated with mortality in young adults.

Mustanoja S, Putaala J, Koivunen RJ, Surakka I, Tatlisumak T.

Eur J Neurol. 2018 Aug;25(8):1034-1040. doi: 10.1111/ene.13662. Epub 2018 May 23.

PMID:
29683540
4.

Hospital readmissions after spontaneous intracerebral hemorrhage in Southern Portugal.

Nzwalo H, Nogueira J, Guilherme P, Abreu P, Félix C, Ferreira F, Ramalhete S, Marreiros A, Tatlisumak T, Thomassen L, Logallo N.

Clin Neurol Neurosurg. 2018 Jun;169:144-148. doi: 10.1016/j.clineuro.2018.04.015. Epub 2018 Apr 12.

PMID:
29665499
5.

Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.

Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, den Hoed M, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S, Bis JC, Pastinen T, Ruusalepp A, Schadt EE, Koplev S, Björkegren JLM, Codoni V, Civelek M, Smith NL, Trégouët DA, Christophersen IE, Roselli C, Lubitz SA, Ellinor PT, Tai ES, Kooner JS, Kato N, He J, van der Harst P, Elliott P, Chambers JC, Takeuchi F, Johnson AD, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M, Malik R, Chauhan G, Traylor M, Sargurupremraj M, Okada Y, Mishra A, Rutten-Jacobs L, Giese AK, van der Laan SW, Gretarsdottir S, Anderson CD, Chong M, Adams HHH, Ago T, Almgren P, Amouyel P, Ay H, Bartz TM, Benavente OR, Bevan S, Boncoraglio GB, Brown RD Jr, Butterworth AS, Carrera C, Carty CL, Chasman DI, Chen WM, Cole JW, Correa A, Cotlarciuc I, Cruchaga C, Danesh J, de Bakker PIW, DeStefano AL, Hoed MD, Duan Q, Engelter ST, Falcone GJ, Gottesman RF, Grewal RP, Gudnason V, Gustafsson S, Haessler J, Harris TB, Hassan A, Havulinna AS, Heckbert SR, Holliday EG, Howard G, Hsu FC, Hyacinth HI, Ikram MA, Ingelsson E, Irvin MR, Jian X, Jiménez-Conde J, Johnson JA, Jukema JW, Kanai M, Keene KL, Kissela BM, Kleindorfer DO, Kooperberg C, Kubo M, Lange LA, Langefeld CD, Langenberg C, Launer LJ, Lee JM, Lemmens R, Leys D, Lewis CM, Lin WY, Lindgren AG, Lorentzen E, Magnusson PK, Maguire J, Manichaikul A, McArdle PF, Meschia JF, Mitchell BD, Mosley TH, Nalls MA, Ninomiya T, O'Donnell MJ, Psaty BM, Pulit SL, Rannikmäe K, Reiner AP, Rexrode KM, Rice K, Rich SS, Ridker PM, Rost NS, Rothwell PM, Rotter JI, Rundek T, Sacco RL, Sakaue S, Sale MM, Salomaa V, Sapkota BR, Schmidt R, Schmidt CO, Schminke U, Sharma P, Slowik A, Sudlow CLM, Tanislav C, Tatlisumak T, Taylor KD, Thijs VNS, Thorleifsson G, Thorsteinsdottir U, Tiedt S, Trompet S, Tzourio C, van Duijn CM, Walters M, Wareham NJ, Wassertheil-Smoller S, Wilson JG, Wiggins KL, Yang Q, Yusuf S, Amin N, Aparicio HS, Arnett DK, Attia J, Beiser AS, Berr C, Buring JE, Bustamante M, Caso V, Cheng YC, Choi SH, Chowhan A, Cullell N, Dartigues JF, Delavaran H, Delgado P, Dörr M, Engström G, Ford I, Gurpreet WS, Hamsten A, Heitsch L, Hozawa A, Ibanez L, Ilinca A, Ingelsson M, Iwasaki M, Jackson RD, Jood K, Jousilahti P, Kaffashian S, Kalra L, Kamouchi M, Kitazono T, Kjartansson O, Kloss M, Koudstaal PJ, Krupinski J, Labovitz DL, Laurie CC, Levi CR, Li L, Lind L, Lindgren CM, Lioutas V, Liu YM, Lopez OL, Makoto H, Martinez-Majander N, Matsuda K, Minegishi N, Montaner J, Morris AP, Muiño E, Müller-Nurasyid M, Norrving B, Ogishima S, Parati EA, Peddareddygari LR, Pedersen NL, Pera J, Perola M, Pezzini A, Pileggi S, Rabionet R, Riba-Llena I, Ribasés M, Romero JR, Roquer J, Rudd AG, Sarin AP, Sarju R, Sarnowski C, Sasaki M, Satizabal CL, Satoh M, Sattar N, Sawada N, Sibolt G, Sigurdsson Á, Smith A, Sobue K, Soriano-Tárraga C, Stanne T, Stine OC, Stott DJ, Strauch K, Takai T, Tanaka H, Tanno K, Teumer A, Tomppo L, Torres-Aguila NP, Touze E, Tsugane S, Uitterlinden AG, Valdimarsson EM, van der Lee SJ, Völzke H, Wakai K, Weir D, Williams SR, Wolfe CDA, Wong Q, Xu H, Yamaji T, Sanghera DK, Melander O, Jern C, Strbian D, Fernandez-Cadenas I, Longstreth WT Jr, Rolfs A, Hata J, Woo D, Rosand J, Pare G, Hopewell JC, Saleheen D, Stefansson K, Worrall BB, Kittner SJ, Seshadri S, Fornage M, Markus HS, Howson JMM, Kamatani Y, Debette S, Dichgans M; AFGen Consortium; Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium; International Genomics of Blood Pressure (iGEN-BP) Consortium; INVENT Consortium; STARNET; BioBank Japan Cooperative Hospital Group; COMPASS Consortium; EPIC-CVD Consortium; EPIC-InterAct Consortium; International Stroke Genetics Consortium (ISGC); METASTROKE Consortium; Neurology Working Group of the CHARGE Consortium; NINDS Stroke Genetics Network (SiGN); UK Young Lacunar DNA Study; MEGASTROKE Consortium; MEGASTROKE Consortium:.

Nat Genet. 2018 Apr;50(4):524-537. doi: 10.1038/s41588-018-0058-3. Epub 2018 Mar 12.

6.

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

Kasner SE, Lavados P, Sharma M, Wang Y, Wang Y, Dávalos A, Shamalov N, Cunha L, Lindgren A, Mikulik R, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi R, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni DS, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, DeVries Basson MM, Endres M, Muir K, Bornstein N, Ozturk S, O'Donnell M, Mundl H, Pater C, Weitz J, Peacock WF, Swaminathan B, Kirsch B, Berkowitz SD, Peters G, Pare G, Themeles E, Shoamanesh A, Connolly SJ, Hart RG; NAVIGATE ESUS Steering Committee and Investigators.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1673-1682. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.027. Epub 2018 Mar 7.

PMID:
29525076
7.

Nontraumatic intracerebral haemorrhage in young adults.

Tatlisumak T, Cucchiara B, Kuroda S, Kasner SE, Putaala J.

Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9. Review.

PMID:
29521335
8.

University education and cervical artery dissection.

Kellert L, Grau A, Pezzini A, Debette S, Leys D, Caso V, Thijs VN, Bersano A, Touzé E, Tatlisumak T, Traenka C, Lyrer PA, Engelter ST, Metso TM, Grond-Ginsbach C, Kloss M; Cervical Artery Dissection and Ischemic Stroke Patients (CADISP)-Study Group.

J Neurol. 2018 May;265(5):1065-1070. doi: 10.1007/s00415-018-8798-7. Epub 2018 Feb 24.

PMID:
29478223
9.

Diabetes and intracerebral hemorrhage: baseline characteristics and mortality.

Liebkind R, Gordin D, Strbian D, Meretoja A, Thorn LM, Hägg-Holmberg S, Forsblom C, Tatlisumak T, Groop PH, Putaala J.

Eur J Neurol. 2018 Jun;25(6):825-832. doi: 10.1111/ene.13603. Epub 2018 Mar 26.

PMID:
29443444
10.

Intravenous thrombolysis and platelet count.

Gensicke H, Al Sultan AS, Strbian D, Hametner C, Zinkstok SM, Moulin S, Bill O, Zini A, Padjen V, Kägi G, Pezzini A, Seiffge DJ, Traenka C, Räty S, Amiri H, Zonneveld TP, Lachenmeier R, Polymeris A, Roos YB, Gumbinger C, Jovanovic DR, Curtze S, Sibolt G, Vandelli L, Ringleb PA, Leys D, Cordonnier C, Michel P, Lyrer PA, Peters N, Tatlisumak T, Nederkoorn PJ, Engelter ST; Thrombolysis in Stroke Patients (TRISP) Collaborators.

Neurology. 2018 Feb 20;90(8):e690-e697. doi: 10.1212/WNL.0000000000004982. Epub 2018 Jan 24.

PMID:
29367438
11.

Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study.

Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, Chondrogianni M, Bovi P, Carletti M, Cappellari M, Zedde M, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Silvestrelli G, Lanari A, Ciccone A, Putaala J, Tomppo L, Tatlisumak T, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D'Amore C, Becattini C, Mosconi MG, Cimini LA, Soloperto R, Masotti L, Vannucchi V, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Sohn SI, Marcheselli S, Mumoli N, De Lodovici ML, Bono G, Furie KL, Tadi P, Yaghi S, Toni D, Letteri F, Tassinari T, Kargiotis O, Lotti EM, Flomin Y, Mancuso M, Maccarrone M, Giannini N, Bandini F, Pezzini A, Poli L, Padovani A, Scoditti U, Denti L, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Gourbali V, Orlandi G, Giuntini M, Chiti A, Giorli E, Gialdini G, Corea F, Ageno W, Bellesini M, Colombo G, Monaco S, Maimone Baronello M, Karapanayiotides T, Caso V.

J Am Heart Assoc. 2017 Nov 29;6(12). pii: e007034. doi: 10.1161/JAHA.117.007034.

12.

Embolic strokes of undetermined source in young adults: baseline characteristics and long-term outcome.

Martinez-Majander N, Aarnio K, Pirinen J, Lumikari T, Nieminen T, Lehto M, Sinisalo J, Kaste M, Tatlisumak T, Putaala J.

Eur J Neurol. 2018 Mar;25(3):535-541. doi: 10.1111/ene.13540. Epub 2018 Jan 19.

PMID:
29218790
13.

Treatment of intracerebellar haemorrhage: Poor outcome and high long-term mortality.

Satopää J, Meretoja A, Koivunen RJ, Mustanoja S, Putaala J, Kaste M, Strbian D, Tatlisumak T, Niemelä MR.

Surg Neurol Int. 2017 Nov 9;8:272. doi: 10.4103/sni.sni_168_17. eCollection 2017.

14.

Cerebral Venous Thrombosis in Older Patients.

Zuurbier SM, Hiltunen S, Lindgren E, Silvis SM, Jood K, Devasagayam S, Kleinig TJ, Silver FL, Mandell DM, Putaala J, Tatlisumak T, Coutinho JM.

Stroke. 2018 Jan;49(1):197-200. doi: 10.1161/STROKEAHA.117.019483. Epub 2017 Dec 4.

PMID:
29203685
15.

Vocational outcome in cerebral venous thrombosis: Long-term follow-up study.

Lindgren E, Jood K, Tatlisumak T.

Acta Neurol Scand. 2018 Mar;137(3):299-307. doi: 10.1111/ane.12875. Epub 2017 Nov 21.

PMID:
29159843
16.

Cancer and risk of cerebral venous thrombosis: a case-control study.

Silvis SM, Hiltunen S, Lindgren E, Jood K, Zuurbier SM, Middeldorp S, Putaala J, Cannegieter SC, Tatlisumak T, Coutinho JM.

J Thromb Haemost. 2018 Jan;16(1):90-95. doi: 10.1111/jth.13903. Epub 2017 Dec 1.

PMID:
29125690
17.

Non-office-hours admission affects intravenous thrombolysis treatment times and clinical outcome.

Zonneveld TP, Curtze S, Zinkstok SM, Gensicke H, Moulin S, Scheitz JF, Seiffge DJ, Hametner C, Heldner MR, Traenka C, Erdur H, Baharoglu I, Martinez-Majander N, Pezzini A, Zini A, Padjen V, Correia PN, Strbian D, Michel P, Béjot Y, Arnold M, Leys D, Ringleb PA, Tatlisumak T, Nolte CH, Engelter ST, Nederkoorn PJ; TRISP collaborators.

J Neurol Neurosurg Psychiatry. 2017 Oct 25. pii: jnnp-2017-316791. doi: 10.1136/jnnp-2017-316791. [Epub ahead of print] No abstract available.

PMID:
29070647
18.

Animal Models of Focal Cerebral Ischaemia and Haemorrhagic Transformation: Considerations in Experimental Stroke Study Design.

Shearer JA, Douglas AS, Kirby BP, Tatlisumak T, Doyle KM.

Curr Vasc Pharmacol. 2017 Sep 5. doi: 10.2174/1570161115666170906115300. [Epub ahead of print]

PMID:
28875831
19.

Beta-blocker therapy is not associated with mortality after intracerebral hemorrhage.

Sykora M, Putaala J, Meretoja A, Tatlisumak T, Strbian D.

Acta Neurol Scand. 2018 Jan;137(1):105-108. doi: 10.1111/ane.12817. Epub 2017 Sep 4.

PMID:
28869294
20.

Prognosis and Its Predictors After Incident Stroke in Patients With Type 1 Diabetes.

Hägg-Holmberg S, Thorn LM, Forsblom CM, Gordin D, Elonen N, Harjutsalo V, Liebkind R, Putaala J, Tatlisumak T, Groop PH; FinnDiane Study Group.

Diabetes Care. 2017 Oct;40(10):1394-1400. doi: 10.2337/dc17-0681. Epub 2017 Aug 15.

PMID:
28811283
21.

Prehospital pathways of occipital stroke patients with mainly visual symptoms.

Räty S, Silvennoinen K, Tatlisumak T.

Acta Neurol Scand. 2018 Jan;137(1):51-58. doi: 10.1111/ane.12807. Epub 2017 Aug 13.

PMID:
28804875
22.

Domain-Specific Cognitive Recovery after First-Ever Stroke: A 2-Year Follow-Up.

Turunen KEA, Laari SPK, Kauranen TV, Uimonen J, Mustanoja S, Tatlisumak T, Poutiainen E.

J Int Neuropsychol Soc. 2018 Feb;24(2):117-127. doi: 10.1017/S1355617717000728. Epub 2017 Aug 9.

PMID:
28791943
23.

Persistent Hyperglycemia Is Associated With Increased Mortality After Intracerebral Hemorrhage.

Wu TY, Putaala J, Sharma G, Strbian D, Tatlisumak T, Davis SM, Meretoja A.

J Am Heart Assoc. 2017 Aug 2;6(8). pii: e005760. doi: 10.1161/JAHA.117.005760.

24.

Dolichoectasia and Small Vessel Disease in Young Patients With Transient Ischemic Attack and Stroke.

Thijs V, Grittner U, Fazekas F, McCabe DJH, Giese AK, Kessler C, Martus P, Norrving B, Ringelstein EB, Schmidt R, Tanislav C, Putaala J, Tatlisumak T, von Sarnowski B, Rolfs A, Enzinger C; Stroke in Fabry (SIFAP1) Investigators.

Stroke. 2017 Sep;48(9):2361-2367. doi: 10.1161/STROKEAHA.117.017406. Epub 2017 Jul 28.

PMID:
28754833
25.

Comparison of all 19 published prognostic scores for intracerebral hemorrhage.

Satopää J, Mustanoja S, Meretoja A, Putaala J, Kaste M, Niemelä M, Tatlisumak T, Strbian D.

J Neurol Sci. 2017 Aug 15;379:103-108. doi: 10.1016/j.jns.2017.05.034. Epub 2017 May 17.

PMID:
28716217
26.

Age- and sex-specific analysis of patients with embolic stroke of undetermined source.

Ntaios G, Lip GYH, Vemmos K, Koroboki E, Manios E, Vemmou A, Rodríguez-Campello A, Cuadrado-Godia E, Roquer J, Arnao V, Caso V, Paciaroni M, Diez-Tejedor E, Fuentes B, Pérez Lucas J, Arauz A, Ameriso SF, Pertierra L, Gómez-Schneider M, Hawkes MA, Bandini F, Chavarria Cano B, Iglesias Mohedano AM, García Pastor A, Gil-Núñez A, Putaala J, Tatlisumak T, Barboza MA, Athanasakis G, Gioulekas F, Makaritsis K, Papavasileiou V.

Neurology. 2017 Aug 8;89(6):532-539. doi: 10.1212/WNL.0000000000004199. Epub 2017 Jul 7.

PMID:
28687720
27.

ECG markers associated with ischemic stroke at young age - a case-control study.

Pirinen J, Eranti A, Knekt P, Lehto M, Martinez-Majander N, Aro AL, Rissanen H, Heliövaara M, Kaste M, Tatlisumak T, Huikuri H, Putaala J.

Ann Med. 2017 Nov;49(7):562-568. doi: 10.1080/07853890.2017.1348620. Epub 2017 Jul 14.

PMID:
28657357
28.

Endovascular therapy for ischemic stroke: Save a minute-save a week.

Meretoja A, Keshtkaran M, Tatlisumak T, Donnan GA, Churilov L.

Neurology. 2017 May 30;88(22):2123-2127. doi: 10.1212/WNL.0000000000003981. Epub 2017 Apr 28.

PMID:
28455382
29.

Genetic Imbalance in Patients with Cervical Artery Dissection.

Grond-Ginsbach C, Chen B, Krawczak M, Pjontek R, Ginsbach P, Jiang Y, Abboud S, Arnold ML, Bersano A, Brandt T, Caso V, Debette S, Dichgans M, Geschwendtner A, Giacalone G, Martin JJ, Metso AJ, Metso TM, Grau AJ, Kloss M, Lichy C, Pezzini A, Traenka C, Schreiber S, Thijs V, Touzé E, Del Zotto E, Tatlisumak T, Leys D, Lyrer PA, Engelter ST; CADISP group.

Curr Genomics. 2017 Apr;18(2):206-213. doi: 10.2174/1389202917666160805152627.

30.

Obesity paradox in stroke - Myth or reality? A systematic review.

Oesch L, Tatlisumak T, Arnold M, Sarikaya H.

PLoS One. 2017 Mar 14;12(3):e0171334. doi: 10.1371/journal.pone.0171334. eCollection 2017. Review.

31.

TIA model is attainable in Wistar rats by intraluminal occlusion of the MCA for 10min or shorter.

Durukan Tolvanen A, Tatlisumak E, Pedrono E, Abo-Ramadan U, Tatlisumak T.

Brain Res. 2017 May 15;1663:166-173. doi: 10.1016/j.brainres.2017.03.010. Epub 2017 Mar 11.

PMID:
28288870
32.

Natural History of Perihematomal Edema and Impact on Outcome After Intracerebral Hemorrhage.

Wu TY, Sharma G, Strbian D, Putaala J, Desmond PM, Tatlisumak T, Davis SM, Meretoja A.

Stroke. 2017 Apr;48(4):873-879. doi: 10.1161/STROKEAHA.116.014416. Epub 2017 Mar 8. Erratum in: Stroke. 2017 Oct;48(10 ):e319.

33.

Cervical artery dissection in patients ≥60 years: Often painless, few mechanical triggers.

Traenka C, Dougoud D, Simonetti BG, Metso TM, Debette S, Pezzini A, Kloss M, Grond-Ginsbach C, Majersik JJ, Worrall BB, Leys D, Baumgartner R, Caso V, Béjot Y, Compter A, Reiner P, Thijs V, Southerland AM, Bersano A, Brandt T, Gensicke H, Touzé E, Martin JJ, Chabriat H, Tatlisumak T, Lyrer P, Arnold M, Engelter ST; CADISP-Plus Study Group.

Neurology. 2017 Apr 4;88(14):1313-1320. doi: 10.1212/WNL.0000000000003788. Epub 2017 Mar 3.

PMID:
28258079
34.

Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study.

Acciarresi M, Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S, Rueckert C, Pezzini A, Morotti A, Costa P, Padovani A, Csiba L, Szabó L, Sohn SI, Tassinari T, Abdul-Rahim AH, Michel P, Cordier M, Vanacker P, Remillard S, Alberti A, Venti M, D'Amore C, Scoditti U, Denti L, Orlandi G, Chiti A, Gialdini G, Bovi P, Carletti M, Rigatelli A, Putaala J, Tatlisumak T, Masotti L, Lorenzini G, Tassi R, Guideri F, Martini G, Tsivgoulis G, Vadikolias K, Liantinioti C, Corea F, Del Sette M, Ageno W, De Lodovici ML, Bono G, Baldi A, D'Anna S, Sacco S, Carolei A, Tiseo C, Imberti D, Zabzuni D, Doronin B, Volodina V, Consoli D, Galati F, Pieroni A, Toni D, Monaco S, Baronello MM, Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Mosconi MG, Lees KR.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1363-1368. doi: 10.1016/j.jstrokecerebrovasdis.2017.02.011. Epub 2017 Feb 22.

PMID:
28236595
35.

Simultaneous Multiple Intracerebral Hemorrhages (SMICH).

Wu TY, Yassi N, Shah DG, Ma M, Sharma G, Putaala J, Strbian D, Campbell BC, Yan B, Tatlisumak T, Desmond PM, Davis SM, Meretoja A.

Stroke. 2017 Mar;48(3):581-586. doi: 10.1161/STROKEAHA.116.015186.

36.

Can natalizumab be beneficial in acute ischaemic stroke?

Tatlisumak T.

Lancet Neurol. 2017 Mar;16(3):176-177. doi: 10.1016/S1474-4422(16)30383-0. Epub 2017 Feb 15. No abstract available.

PMID:
28229882
37.

Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.

Paciaroni M, Agnelli G, Caso V, Tsivgoulis G, Furie KL, Tadi P, Becattini C, Falocci N, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D'Amore C, Mosconi MG, Cimini LA, Procopio A, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Bandini F, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Colombo G, Silvestrelli G, Ciccone A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D'Anna S, Toni D, Letteri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Baronello MM, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Kepplinger J, Bodechtel U, Gerber J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Yaghi S.

Stroke. 2017 Mar;48(3):726-732. doi: 10.1161/STROKEAHA.116.015770. Epub 2017 Feb 9.

38.

Strength of ~20-Hz Rebound and Motor Recovery After Stroke.

Parkkonen E, Laaksonen K, Piitulainen H, Pekkola J, Parkkonen L, Tatlisumak T, Forss N.

Neurorehabil Neural Repair. 2017 May;31(5):475-486. doi: 10.1177/1545968316688795. Epub 2017 Feb 4.

PMID:
28164736
39.

Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults.

Yesilot N, Putaala J, Bahar SZ, Tatlısumak T.

Curr Vasc Pharmacol. 2017;15(5):416-429. doi: 10.2174/1570161115666170202161719. Review.

PMID:
28155625
40.

Posterior versus Anterior Circulation Stroke in Young Adults: A Comparative Study of Stroke Aetiologies and Risk Factors in Stroke among Young Fabry Patients (sifap1).

von Sarnowski B, Schminke U, Grittner U, Tanislav C, Böttcher T, Hennerici MG, Tatlisumak T, Putaala J, Kaps M, Fazekas F, Enzinger C, Rolfs A, Kessler C; sifap1 Investigators.

Cerebrovasc Dis. 2017;43(3-4):152-160. doi: 10.1159/000454840. Epub 2017 Jan 14.

PMID:
28088807
41.

Patent Foramen Ovale and Cryptogenic Strokes in the Stroke in Young Fabry Patients Study.

Huber R, Grittner U, Weidemann F, Thijs V, Tanislav C, Enzinger C, Fazekas F, Wolf M, Hennerici MG, McCabe DJ, Putaala J, Tatlisumak T, Kessler C, von Sarnowski B, Martus P, Kolodny E, Norrving B, Rolfs A; Stroke in Young Fabry Patients (SIFAP) Investigators.

Stroke. 2017 Jan;48(1):30-35. doi: 10.1161/STROKEAHA.116.013620. Epub 2016 Nov 29.

42.

Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol.

Cotlarciuc I, Marjot T, Khan MS, Hiltunen S, Haapaniemi E, Metso TM, Putaala J, Zuurbier SM, Brouwer MC, Passamonti SM, Bucciarelli P, Pappalardo E, Patel T, Costa P, Colombi M, Canhão P, Tkach A, Santacroce R, Margaglione M, Favuzzi G, Grandone E, Colaizzo D, Spengos K, Arauz A, Hodge A, Ditta R, Debette S, Zedde M, Pare G, Ferro JM, Thijs V, Pezzini A, Majersik JJ, Martinelli I, Coutinho JM, Tatlisumak T, Sharma P; ISGC (International Stroke Genetics Consortium) and BEAST investigators.

BMJ Open. 2016 Nov 22;6(11):e012351. doi: 10.1136/bmjopen-2016-012351.

43.

Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.

Gensicke H, Frih AA, Strbian D, Zini A, Pezzini A, Padjen V, Haueter M, Seiffge DJ, Mäkitie L, Traenka C, Poli L, Martinez-Majander N, Putaala J, Bonati LH, Sibolt G, Giovannini G, Curtze S, Beslac-Bumbasirevic L, Vandelli L, Lyrer PA, Nederkoorn PJ, Tatlisumak T, Engelter ST; Thrombolysis in Stroke Patients (TRISP) Collaborators.

Eur J Neurol. 2017 Feb;24(2):262-269. doi: 10.1111/ene.13179. Epub 2016 Nov 10.

PMID:
27862667
44.

Stroke Thrombolysis in a Centralized and a Decentralized System (Helsinki and Telemedical Project for Integrative Stroke Care Network).

Hubert GJ, Meretoja A, Audebert HJ, Tatlisumak T, Zeman F, Boy S, Haberl RL, Kaste M, Müller-Barna P.

Stroke. 2016 Dec;47(12):2999-3004. Epub 2016 Nov 10.

45.

Are 12-lead ECG findings associated with the risk of cardiovascular events after ischemic stroke in young adults?

Pirinen J, Putaala J, Aarnio K, Aro AL, Sinisalo J, Kaste M, Haapaniemi E, Tatlisumak T, Lehto M.

Ann Med. 2016 Nov;48(7):532-540. Epub 2016 Sep 29.

PMID:
27684300
46.

Ultra-acute diagnostics for stroke: Large-scale implementation of prehospital biomarker sampling.

Mattila OS, Harve H, Pihlasviita S, Ritvonen J, Sibolt G, Pystynen M, Strbian D, Curtze S, Kuisma M, Tatlisumak T, Lindsberg PJ.

Acta Neurol Scand. 2017 Jul;136(1):17-23. doi: 10.1111/ane.12687. Epub 2016 Sep 18.

PMID:
27642014
47.

Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.

Saarela M, Mustanoja S, Pekkola J, Tyni T, Hernesniemi J, Kivipelto L, Tatlisumak T.

Int J Stroke. 2017 Jan;12(1):90-95. doi: 10.1177/1747493016669847. Epub 2016 Sep 24.

PMID:
27625049
48.

Symptomatic post-thrombolytic intracerebral hemorrhage is not related to the cause of stroke.

Curtze S, Sibolt G, Melkas S, Mustanoja S, Haapaniemi E, Putaala J, Sairanen T, Tiainen M, Tatlisumak T, Strbian D.

Eur J Neurol. 2016 Dec;23(12):1700-1704. doi: 10.1111/ene.13128. Epub 2016 Sep 3.

PMID:
27591741
49.

Cerebral white matter lesions and post-thrombolytic remote parenchymal hemorrhage.

Curtze S, Putaala J, Sibolt G, Melkas S, Mustanoja S, Haapaniemi E, Sairanen T, Tiainen M, Tatlisumak T, Strbian D.

Ann Neurol. 2016 Oct;80(4):593-9. doi: 10.1002/ana.24760. Epub 2016 Aug 26.

PMID:
27531598
50.

Post-thrombolytic blood pressure and symptomatic intracerebral hemorrhage.

Waltimo T, Haapaniemi E, Surakka IL, Melkas S, Sairanen T, Sibolt G, Tatlisumak T, Strbian D.

Eur J Neurol. 2016 Dec;23(12):1757-1762. doi: 10.1111/ene.13118. Epub 2016 Aug 16.

PMID:
27529662

Supplemental Content

Loading ...
Support Center